Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for Endothelial Function in Familial Hypercholesterolemia
NCT01813006Phase 3Completed
- Sponsor
- Nordlandssykehuset
- Start
- Mar 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Omega-3 with Placebo (2 arms). Primary endpoint: Reactive Hyperemia Index at 9 months. Started Mar 2013; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT01813006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813006.